Lupin Buys Stake In South Africa’s Pharma Dynamics; Aims To Be In Top 3
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - After months of negotiations, Indian generic drug maker Lupin acquired a 60 percent equity stake in South Africa's sixth largest generic drug maker Pharma Dynamics with the goal of joining the top ranks of companies in South Africa in three years